Fidelity Investments’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,997
| Closed | -$11.7K | – | 5633 |
|
|
2022
Q4 | $11.7K | Buy |
+1,997
| New | +$11.7K | ﹤0.01% | 3955 |
|
|
2021
Q4 | – | Sell |
-775
| Closed | -$3K | – | 5145 |
|
|
2021
Q3 | $3K | Buy |
775
+355
| +85% | +$1.37K | ﹤0.01% | 3956 |
|
|
2021
Q2 | $2K | Buy |
420
+20
| +5% | +$95 | ﹤0.01% | 3976 |
|
|
2021
Q1 | $2K | Buy |
+400
| New | +$2K | ﹤0.01% | 3769 |
|
|
2018
Q4 | – | Sell |
-61
| Closed | -$1K | – | 4317 |
|
|
2018
Q3 | $1K | Buy |
+61
| New | +$1K | ﹤0.01% | 3477 |
|
|
2017
Q1 | – | Sell |
-100,000
| Closed | -$1.03M | – | 2722 |
|
|
2016
Q4 | $1.03M | Buy |
100,000
+15,056
| +18% | +$155K | ﹤0.01% | 2468 |
|
|
2016
Q3 | $859K | Buy |
84,944
+29,769
| +54% | +$301K | ﹤0.01% | 2480 |
|
|
2016
Q2 | $620K | Buy |
+55,175
| New | +$620K | ﹤0.01% | 2521 |
|
|
2016
Q1 | – | Sell |
-180,925
| Closed | -$3.43M | – | 2761 |
|
|
2015
Q4 | $3.43M | Buy |
180,925
+5,000
| +3% | +$94.8K | ﹤0.01% | 2302 |
|
|
2015
Q3 | $3.3M | Buy |
+175,925
| New | +$3.3M | ﹤0.01% | 2287 |
|
|
2014
Q4 | – | Sell |
-33,953
| Closed | -$428K | – | 2861 |
|
|
2014
Q3 | $428K | Buy |
+33,953
| New | +$428K | ﹤0.01% | 2648 |
|